ATE416759T1 - Im mundraum dispergierende brausetabletten - Google Patents

Im mundraum dispergierende brausetabletten

Info

Publication number
ATE416759T1
ATE416759T1 AT02727667T AT02727667T ATE416759T1 AT E416759 T1 ATE416759 T1 AT E416759T1 AT 02727667 T AT02727667 T AT 02727667T AT 02727667 T AT02727667 T AT 02727667T AT E416759 T1 ATE416759 T1 AT E416759T1
Authority
AT
Austria
Prior art keywords
agent
effortable
tablets
dispersing
seconds
Prior art date
Application number
AT02727667T
Other languages
English (en)
Inventor
Pascal Delmas
Jean-Marc Zuccarelli
Claire Mallard
James Mcginity
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Application granted granted Critical
Publication of ATE416759T1 publication Critical patent/ATE416759T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
AT02727667T 2001-04-20 2002-04-17 Im mundraum dispergierende brausetabletten ATE416759T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0105389A FR2823668B1 (fr) 2001-04-20 2001-04-20 Comprimes effervescents orodispersibles

Publications (1)

Publication Number Publication Date
ATE416759T1 true ATE416759T1 (de) 2008-12-15

Family

ID=8862540

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02727667T ATE416759T1 (de) 2001-04-20 2002-04-17 Im mundraum dispergierende brausetabletten

Country Status (15)

Country Link
US (1) US20040265380A1 (de)
EP (1) EP1379222B1 (de)
JP (1) JP2004525976A (de)
CN (1) CN1633282A (de)
AT (1) ATE416759T1 (de)
CA (1) CA2444506C (de)
CY (1) CY1108873T1 (de)
DE (1) DE60230249D1 (de)
DK (1) DK1379222T3 (de)
ES (1) ES2319266T3 (de)
FR (1) FR2823668B1 (de)
HK (1) HK1062404A1 (de)
MX (1) MXPA03009587A (de)
PT (1) PT1379222E (de)
WO (1) WO2002085336A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible
US20030228370A1 (en) * 2002-06-11 2003-12-11 Michel Serpelloni Orodispersible solid pharmaceutical form
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8545881B2 (en) 2004-04-19 2013-10-01 Eurand Pharmaceuticals, Ltd. Orally disintegrating tablets and methods of manufacture
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US20060039971A1 (en) * 2004-08-19 2006-02-23 Lee Robert E Effervescent composition including alternative hormone replacement therapy agent
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
CA2584957C (en) 2004-10-21 2015-08-25 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
JP2006182679A (ja) * 2004-12-27 2006-07-13 Daicho Kikaku:Kk ストレス性胃炎予防・治療剤
DE102005009240A1 (de) 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
CA2612917A1 (en) * 2005-06-23 2007-01-04 Schering Corporation Rapidly absorbing oral formulations of pde5 inhibitors
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
PE20070698A1 (es) * 2005-11-14 2007-08-17 Teijin Pharma Ltd Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
CA2648280C (en) 2006-04-03 2014-03-11 Isa Odidi Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
EP1902708A1 (de) * 2006-09-25 2008-03-26 Losan Pharma GmbH Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung
CN101938984A (zh) * 2008-02-08 2011-01-05 高露洁-棕榄公司 清洁用组合物和方法
FR2938431B1 (fr) 2008-11-14 2013-12-20 Debregeas Et Associes Pharma Nouvelle composition a base d'acide gamma-hydroxybutyrique
PL387415A1 (pl) * 2009-03-06 2010-09-13 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Kompozycja farmaceutyczna zawierająca celekoksyb oraz sposób jej wytwarzania
JPWO2010119490A1 (ja) * 2009-04-14 2012-10-18 パナソニック株式会社 立体映像表示装置
US20110097401A1 (en) 2009-06-12 2011-04-28 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
FR2949062B1 (fr) 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
FR2949061B1 (fr) 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
WO2011067667A2 (en) 2009-12-02 2011-06-09 Eurand Pharmaceuticals Limited Fexofenadine microcapsules and compositions containing them
WO2011101734A2 (en) 2010-02-22 2011-08-25 Lupin Limited Taste-masked powder for suspension compositions of methylprednisolone
US20150231092A1 (en) * 2012-08-17 2015-08-20 Sanovell IIac Sanayi Ve Ticaret Anonim Sirketi Novel effervescent sachet formulations of dapoxetine and a pde5 inhibitor
WO2014027981A2 (en) * 2012-08-17 2014-02-20 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Effervescent tablet formulations of dapoxetine and a pde5 inhibitor
FR3013221B1 (fr) * 2013-11-19 2020-11-27 Nabil Said Composition pharmaceutique effervescente a base de sildenafil et son procede de fabrication
CA3018828C (en) * 2014-09-17 2021-05-11 Steerlife India Private Limited Effervescent composition and method of making it
CN104224744A (zh) * 2014-09-28 2014-12-24 严相顺 用于家蚕细菌病防治的环丙沙星泡腾片
WO2017098481A1 (en) 2015-12-12 2017-06-15 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
JP7166636B2 (ja) * 2016-07-15 2022-11-08 エイチツー ウォーター テクノロジーズ リミテッド 水素豊富水を生成するための組成物及び他の製品
GR1009573B (el) * 2018-03-28 2019-08-12 Λαμδα Φαρμακευτικα Εργαστηρια Εφαρμοσμενης Ερευνας Και Αναπτυξης Α.Ε. Αναβραζοντα φαρμακευτικα δισκια που περιλαμβανουν νατριοφωσφορικη υδροκορτιζονη
CN117813089A (zh) * 2021-07-09 2024-04-02 美国纳米食品药品公司 环氧合酶-2（cox-2）抑制剂组合物的制造方法
CN115843813B (zh) * 2023-02-23 2023-05-12 山东金佑星水环境科技有限公司 一种复方氯溴泡腾速溶消毒片及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2097155T3 (es) * 1989-10-02 1997-04-01 Cima Labs Inc Forma de dosificacion efervescente y metodo de administracion.
US6709678B2 (en) * 1996-08-15 2004-03-23 Losan Pharma Gmbh Easy to swallow oral medicament composition
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
US6071539A (en) * 1996-09-20 2000-06-06 Ethypharm, Sa Effervescent granules and methods for their preparation
DE19822036A1 (de) * 1998-05-15 1999-11-18 Bayer Ag Brausezubereitungen
US20020160048A1 (en) * 2001-02-15 2002-10-31 Karoline Bechtold-Peters Medical formulation containing a muscarinic agonist

Also Published As

Publication number Publication date
WO2002085336A1 (fr) 2002-10-31
MXPA03009587A (es) 2004-12-06
DE60230249D1 (de) 2009-01-22
HK1062404A1 (en) 2004-11-05
JP2004525976A (ja) 2004-08-26
EP1379222B1 (de) 2008-12-10
PT1379222E (pt) 2009-03-16
FR2823668A1 (fr) 2002-10-25
CA2444506A1 (fr) 2002-10-31
EP1379222A1 (de) 2004-01-14
DK1379222T3 (da) 2009-04-14
FR2823668B1 (fr) 2004-02-27
CA2444506C (fr) 2010-08-10
ES2319266T3 (es) 2009-05-06
CY1108873T1 (el) 2014-07-02
US20040265380A1 (en) 2004-12-30
CN1633282A (zh) 2005-06-29

Similar Documents

Publication Publication Date Title
ATE416759T1 (de) Im mundraum dispergierende brausetabletten
ZA991408B (en) Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent.
PT893992E (pt) Formas de dosagem oral de desintegracao rapida
WO2003053417A3 (fr) Procede de fabrication d'un comprime incluant un analgesique de type morphinique et comprime obtenu
DK1003486T3 (da) Farmaceutisk præparat indeholdende et bruse-syre-basepar
WO2002043719A3 (en) Composition and method for treating snoring
ATE431738T1 (de) Opioid-agonist-formulierungen mit freisetzbarem und sequestriertem antagonist
TR200101224T2 (tr) Hızlı bir biçimde dağılan gelişkin tablet.
TR200001942T2 (tr) Opioid agonist/antagonist kombinasyonlar
NO20043998L (no) Oral administreringsform for tungtloselige basiske aktive virkestoffer
BR9912979B1 (pt) composição farmacêutica administrável oralmente, tablete de mascar, cápsula e uso de chitosan.
NO20043441L (no) Orodispersibel farmasoytisk sammensetning omfattende agomelatin
EP1967067A3 (de) Verwendung von Neuronennatriumkanal-Antagonisten mit Amitraz zur Steuerung von Ektoparasiten in homeothermischen Tieren
BR0213449A (pt) Comprimido mastigável contendo lisina
ATE258788T1 (de) Tablette
WO2004071156A3 (en) Use of edible acid in fast-dispersing pharmaceutical solid dosage forms
DE69813846T2 (de) Geschmacksmaskierung schlecht schmeckender formulierungen
WO2003028624A3 (en) Levothyroxine compositions and methods
NO20030988L (no) Anvendelse av en sammensetning omfattende et pollenekstrakt for behandlingav hormonrelaterte forstyrrelser
TW200621304A (en) Pharmaceutical composition
EA200200839A1 (ru) Композиции с контролируемым высвобождением, содержащие агонист и антагонист опиоидов
WO2004014318A3 (en) Levothyroxine compositions and methods
WO2003013441A3 (en) Levothyroxine compositions and methods
WO2002080962A8 (en) Papaine containing pharmaceutical formulation resp. its use
RU2002112882A (ru) Способ повышения резистентности сухостойных коров

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1379222

Country of ref document: EP